Literature DB >> 3222564

Rate of ventilatory acclimatization to extreme altitude.

J B West1.   

Abstract

One of the most important factors in the acclimatization of lowlanders to high altitude is hyperventilation which helps to defend the alveolar PO2. However, how rapidly this occurs at very high altitude is poorly understood. Information can be obtained by comparing the alveolar gas values reported from the extended low pressure chamber studies, Operation Everest I and II, and the American medical research expedition to Everest (AMREE) of 1981. Rahn and Otis (1949) reported the alveolar PO2 and PCO2 values for non-acclimatized and well-acclimatized man on an O2-CO2 diagram, and pointed out that the Operation Everest I data fell approximately halfway between the two curves. The AMREE data agree well with the fully-acclimatized curve, and the Operation Everest II values are intermediate. The differences can be partly, though not wholly, attributed to the different periods of acclimatization. The conclusion is that 31 and 36 days are inadequate periods of acclimatization for altitudes over 8000 m, but that 77 days is sufficient. However, other factors are also involved.

Entities:  

Mesh:

Year:  1988        PMID: 3222564     DOI: 10.1016/0034-5687(88)90040-0

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  4 in total

1.  Exercise breathing pattern during chronic altitude exposure.

Authors:  I B Mekjavic; C Moric; S V Goldberg; J B Morrison; M L Walsh; E W Banister; R B Schoene
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

2.  On maximal oxygen consumption in hypoxic humans.

Authors:  G Ferretti
Journal:  Experientia       Date:  1990-12-01

3.  The decrease of maximal oxygen consumption during hypoxia in man: a mirror image of the oxygen equilibrium curve.

Authors:  G Ferretti; C Moia; J M Thomet; B Kayser
Journal:  J Physiol       Date:  1997-01-01       Impact factor: 5.182

4.  Plasma adenosine during investigation of hypoxic ventilatory response.

Authors:  Dirk Drumm; Markus Hoefer; Janos Juhász; Eva Huszár; Gerhard W Sybrecht
Journal:  Sleep Breath       Date:  2004-03       Impact factor: 2.816

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.